Retraction
Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway
Paper Information
Record ID:
52832
Author(s):
Journal:
Publication Date:
August 25, 2018
Retraction Date:
March 23, 2024
(1.7 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (19)
19
Total Citations1
Post-Retraction(5.3%)
18
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
315
Days since retraction (latest)
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills et al. (4 authors)
Pharmacology & Therapeutics
Published: Feb 2025
4 citations
4 citations
315 days after retraction
New fungal protein from Pleurotus ferulae lanzi induces AMPK-mediated autophagy and G1-phase cell cycle arrest in A549 lung cancer cells
Meng‐Han Liu, Fang Liu, Tzi Bun Ng et al. (4 authors)
International Journal of Biological Macromolecules
Published: Jun 2023
6 citations
6 citations
281 days before retraction
From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer
Beibei Chen, Huihui Hu, Xiaobing Chen
Frontiers in Genetics
Open Access
Published: Feb 2023
5 citations
5 citations
393 days before retraction
Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways
Eisa Sabouni, Melina Maghsodlou Nejad, Sarah Mojtabavi et al. (18 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Feb 2023
47 citations
47 citations
402 days before retraction
Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies
Samhita De, Sourav Paul, Anirban Manna et al. (15 authors)
Cancers
Open Access
Published: Feb 2023
40 citations
40 citations
414 days before retraction
Euxanthone Suppresses the Proliferation, Migration and Invasion of Human Medulloblastoma Cells by Inhibiting the RANK/RANKL Pathway
Chengyan Xu, Zixia He, Zhi-peng Shen
Pharmacognosy Magazine
Open Access
Published: Dec 2022
460 days before retraction
Plant secondary metabolites for the prevention and treatment of colorectal cancer: A review
Raju Senthil Kumar, Praveen Sekar, Shridharshini Kumar et al. (6 authors)
Journal of Pharmacognosy and Phytochemistry
Open Access
Published: Mar 2022
7 citations
7 citations
753 days before retraction
Integrative assessment of CIP2A overexpression and mutational effects in human malignancies identifies possible deleterious variants
Mohammad Tarek, Ahmed Yahia, Mostafa Elnakib et al. (4 authors)
Computers in Biology and Medicine
Published: Oct 2021
9 citations
9 citations
875 days before retraction
Modulatory effect of euxanthone in liver cancer-bearing obese mice: crosstalk between PPARγ and TIMP3 signalling axes
Xu Wang, Zhanhong Wang, Qian Wang et al. (4 authors)
3 Biotech
Open Access
Published: Oct 2021
2 citations
2 citations
886 days before retraction
Pyroptosis, a New Breakthrough in Cancer Treatment
Dengqiang Wu, Changhong Wei, Yujie Li et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Jul 2021
43 citations
43 citations
971 days before retraction
Bioconversion by gut microbiota of predigested mango (Mangifera indica L) ‘Ataulfo’ peel polyphenols assessed in a dynamic (TIM-2) in vitro model of the human colon
Sonia G. Sáyago‐Ayerdi, Koen Venema, María Tabernero et al. (6 authors)
Food Research International
Open Access
Published: Dec 2020
25 citations
25 citations
1201 days before retraction
Retraction Note to: Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS/HIF-1a/VEGF signaling pathway
Jie Zhang, Qian Wang, Qiang Wang et al. (9 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: Nov 2020
3 citations
3 citations
1213 days before retraction
Euxanthone represses the proliferation, migration, and invasion of glioblastoma cells by modulating STAT3/SHP‐1 signaling
Wen Li, DU Hong-mei, Guannan Zhou et al. (4 authors)
The Anatomical Record
Open Access
Published: Jan 2020
6 citations
6 citations
1534 days before retraction
A review on the phytopharmacological studies of the genus Polygala
Marie‐Aleth Lacaille‐Dubois, Clément Delaude, Anne‐Claire Mitaine‐Offer
Journal of Ethnopharmacology
Open Access
Published: Nov 2019
41 citations
41 citations
1583 days before retraction
Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma
Qinsheng Hu, Shijie Zhou, Xuefeng Hu et al. (6 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Nov 2019
21 citations
21 citations
1586 days before retraction
<i>Retracted</i>: Amentoflavone Promotes Apoptosis in Non‐Small‐Cell Lung Cancer by Modulating Cancerous Inhibitor of PP2A
Fei Shen, Yijiang Chen, Liang Chen et al. (6 authors)
The Anatomical Record
Open Access
Published: Aug 2019
13 citations
13 citations
1676 days before retraction
Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer
Jinxia Zhao, Junhua Xu, Jing Lv
Pharmacological Reports
Published: May 2019
5 citations
5 citations
1759 days before retraction
RETRACTED: Alpinumisoflavone causes DNA damage in Colorectal Cancer Cells via blocking DNA repair mediated by RAD51
Li Dong, Xiaoyan Li, LI Gen-qu et al. (7 authors)
Life Sciences
Published: Nov 2018
16 citations
16 citations
1954 days before retraction
Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways
Salvatore Chirumbolo, Geir Bjørklund, Roman Lysiuk et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2018
102 citations
102 citations
1958 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025